Off-label use of medication may be presented in these guidelines if a sufficient level of
evidence shows that it can be considered medically appropriate to a given condition and if …

Individuals with SARS-CoV-2 infection can develop symptoms that persist well beyond the
acute phase of COVID-19 or emerge after the acute phase, lasting for weeks or months after …

The scale of the COVID‐19 pandemic means that a significant number of patients who have
previously been infected with SARS‐CoV‐2 will require surgery. Given the potential for …

Objective: To assess the association between the timing of surgery relative to the
development of Covid-19 and the risks of postoperative complications. Summary …

The impact of vaccination and new SARS‐CoV‐2 variants on peri‐operative outcomes is
unclear. We aimed to update previously published consensus recommendations on timing …

Summary Peri‐operative SARS‐CoV‐2 infection increases postoperative mortality. The aim
of this study was to determine the optimal duration of planned delay before surgery in …

Objective: To evaluate whether COVID-19 vaccination status or mode of anesthesia
modified the temporal harms associated with surgery following coronavirus disease-2019 …

SARS-CoV-2 has been associated with an increased rate of venous thromboembolism in
critically ill patients. Since surgical patients are already at higher risk of venous …

COVID-19, a respiratory viral infection, has affected 388 million individuals worldwide as of
the February 4, 2022. In this review, we have outlined the important liver manifestations of …

Importance The time interval between COVID-19 infection and surgery is a potentially
modifiable but understudied risk factor for postoperative complications. Objective To …